Chimerix Announces Final Data from AdVise Trial of Brincidofovir at BMT Tandem Meetings
Feb 22, 2017 13:01 pm UTC| Business
-- Results show higher survival rate in adenovirus-infected patients with a virologic response to brincidofovir ---- Mortality rates were lower in pediatric patients than in adult patients -- DURHAM, N.C., Feb. 22, 2017...
Holiday Inn® Charlotte Center City Appoints New Director of Sales and Marketing
Feb 22, 2017 13:01 pm UTC| Business
CHARLOTTE, N.C., Feb. 22, 2017 -- The Holiday Inn Charlotte Center City hotel, located in the heart of Uptown and Charlotte’s Business and Entertainment District, is pleased to announce the promotion of Jami Horton Hill...
NXP Launches Multi-Standard Programmable Family of System on Chip Solutions
Feb 22, 2017 13:01 pm UTC| Business
BARCELONA, Spain, Feb. 22, 2017 -- NXP Semiconductors™ N.V. (NASDAQ:NXPI), a worldwide leader in advanced secure connectivity solutions, today announced a new family of fully programmable, multi-standard SoCs for...
Quotient Limited to Participate in the Cowen and Company 37th Annual Health Care Conference
Feb 22, 2017 13:01 pm UTC| Business
JERSEY, Channel Islands, Feb. 22, 2017 -- Quotient Limited (NASDAQ:QTNT), a commercial-stage diagnostics company, today announced that the Company's Chairman and Chief Executive Officer, Paul Cowan, will present at the...
Feb 22, 2017 13:01 pm UTC| Business
ST. LOUIS, Feb. 22, 2017 -- ButcherJoseph Co. (“ButcherJoseph”) served as exclusive financial advisor to Superior Fabrication, Inc. (“Superior” or the “Company”) in its sale from the Superior Fabrication Employee Stock...
Qorvo® To Unveil New RF Solutions at Mobile World Congress 2017
Feb 22, 2017 13:01 pm UTC| Business
GREENSBORO, N.C., Feb. 22, 2017 -- Qorvo® (Nasdaq:QRVO), a leading provider of innovative RF solutions that connect the world, today announced it will showcase its expanding portfolio of radio frequency (RF) solutions...
Feb 22, 2017 13:01 pm UTC| Business
BEDMINSTER, N.J., and DUBLIN, Ireland, Feb. 22, 2017 -- Amarin Corporation plc (NASDAQ:AMRN), a biopharmaceutical company focused on the commercialization and development of therapeutics to improve cardiovascular...